BR0103048A - Derivados de n-triazolilmetil-piperazina como antagonistas de receptores de neuroquinina - Google Patents

Derivados de n-triazolilmetil-piperazina como antagonistas de receptores de neuroquinina

Info

Publication number
BR0103048A
BR0103048A BR0103048-5A BR0103048A BR0103048A BR 0103048 A BR0103048 A BR 0103048A BR 0103048 A BR0103048 A BR 0103048A BR 0103048 A BR0103048 A BR 0103048A
Authority
BR
Brazil
Prior art keywords
triazolylmethyl
receptor antagonists
piperazine derivatives
neurokinin receptor
processes
Prior art date
Application number
BR0103048-5A
Other languages
English (en)
Inventor
Daniel Jasserand
Uwe Schoen
Holger Sann
Reinhard Brueckner
Christian Eeckhout
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of BR0103048A publication Critical patent/BR0103048A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Abstract

Patente de Invenção: "DERIVADOS DE N-TRIAZOLILMETIL-PIPERAZINA COMO ANTAGONISTAS DE RECEPTORES DE NEUROQUININA". São descritos novos derivados de N-triazolilmetil-piperazina, que constituem eficazes antagonistas de receptores de neuroquininina, de fórmula geral I em que R^ 1^, R^ 2^ e R^ 3^ possuem os significados mencionados na descrição, bem como medicamentos que contêm estes compostos. Para além disso, são descritos processos para a preparação dos novos compostos e produtos intermediários destes processos.
BR0103048-5A 2000-07-28 2001-07-26 Derivados de n-triazolilmetil-piperazina como antagonistas de receptores de neuroquinina BR0103048A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10036818A DE10036818A1 (de) 2000-07-28 2000-07-28 Neue N-Triazolylmethyl-Piperazinderivate als Neurokininrezeptor-Antagonisten

Publications (1)

Publication Number Publication Date
BR0103048A true BR0103048A (pt) 2002-04-02

Family

ID=7650544

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0103048-5A BR0103048A (pt) 2000-07-28 2001-07-26 Derivados de n-triazolilmetil-piperazina como antagonistas de receptores de neuroquinina

Country Status (28)

Country Link
US (1) US6407106B1 (pt)
EP (1) EP1176144B1 (pt)
JP (1) JP2002053577A (pt)
KR (1) KR100924405B1 (pt)
CN (1) CN1167698C (pt)
AR (1) AR028743A1 (pt)
AT (1) ATE244716T1 (pt)
AU (1) AU779318B2 (pt)
BR (1) BR0103048A (pt)
CA (1) CA2354213C (pt)
CZ (1) CZ301695B6 (pt)
DE (2) DE10036818A1 (pt)
DK (1) DK1176144T3 (pt)
DZ (1) DZ3119A1 (pt)
ES (1) ES2201007T3 (pt)
HK (1) HK1042699A1 (pt)
HU (1) HU226687B1 (pt)
IL (1) IL144299A (pt)
IN (1) IN191021B (pt)
NO (1) NO323233B1 (pt)
NZ (1) NZ513041A (pt)
PL (1) PL210436B1 (pt)
PT (1) PT1176144E (pt)
RU (1) RU2288918C2 (pt)
SK (1) SK284802B6 (pt)
TW (1) TWI304403B (pt)
UA (1) UA73728C2 (pt)
ZA (1) ZA200105737B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA77515C2 (en) 2002-04-04 2006-12-15 Diazabicyclo alkane derivatives possessing neuroldnin-nk1 receptor antagonistic activity
BR0309486A (pt) * 2002-04-26 2005-02-09 Lilly Co Eli Composto ou um seu sal farmaceuticamente aceitável, composição farmacêutica, e, método para o tratamento de uma condição associada com um excesso de taquicininas
CA2483159C (en) * 2002-04-26 2010-08-10 Eli Lilly And Company Triazole derivatives as tachykinin receptor antagonists
US20060160794A1 (en) * 2003-06-12 2006-07-20 Amegadzie Albert K Tachykinin receptor antagonists
US20070082905A1 (en) * 2005-05-27 2007-04-12 De Vries Michiel H Pharmaceutical compositions comprising n-triazolymethyl-piperazine compounds and methods of using same
CN101228137B (zh) * 2005-07-25 2010-09-29 弗·哈夫曼-拉罗切有限公司 被取代的***衍生物和它们作为神经激肽3受体拮抗剂的用途
PE20081229A1 (es) * 2006-12-01 2008-08-28 Merck & Co Inc Antagonistas de receptor de orexina de diazepam sustituido
EP2129381A1 (en) 2007-01-24 2009-12-09 Glaxo Group Limited Pharmaceutical compositions comprising 3, 5-diamin0-6- (2, 3-dichl0phenyl) -l, 2, 4-triazine or r (-) -2, 4-diamino-5- (2, 3-dichlorophenyl) -6-fluoromethyl pyrimidine and an nk1
US20120258093A1 (en) 2009-08-20 2012-10-11 Institut National De La Sante Et De La Recherche Medicale (Inserm) Vla-4 as a biomarker for prognosis and target for therapy in duchenne muscular dystrophy
ES2672099T3 (es) 2011-07-04 2018-06-12 Irbm - Science Park S.P.A. Antagonistas del receptor NK-1 para el tratamiento de la neovascularización corneal
US20210015834A1 (en) 2018-02-26 2021-01-21 Ospedale San Raffaele S.R.L. Nk-1 antagonists for use in the treatment of ocular pain
US20230134843A1 (en) 2020-03-11 2023-05-04 Ospedale San Raffaele S.R.L. Treatment of stem cell deficiency
CN115184498B (zh) * 2022-07-15 2023-02-21 山东京卫制药有限公司 N-Boc-哌嗪中有关物质哌嗪的检测方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111730A (en) 1993-11-29 1998-12-06 Fujisawa Pharmaceutical Co Piperazine derivatives, processes for their preparation and pharmaceutical preparations containing them
US5883098A (en) 1993-11-29 1999-03-16 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives
AU706021B2 (en) * 1995-05-25 1999-06-03 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives
GB9513118D0 (en) * 1995-06-28 1995-08-30 Merck Sharp & Dohme Therapeutic agents
US6087357A (en) * 1995-12-18 2000-07-11 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives as tachykinin antagonists
KR100458346B1 (ko) * 1996-03-29 2005-06-21 듀파 인터내셔날 리서치 베 파우 피페라진및피페리딘화합물
AUPO735997A0 (en) * 1997-06-17 1997-07-10 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives
DE59814233D1 (de) * 1997-08-27 2008-07-03 Solvay Pharm Gmbh Indolmethyl-N,N'-bisacylpiperazine als Neurokininrezeptorantagonisten
DE19824865A1 (de) * 1997-08-27 1999-03-04 Solvay Pharm Gmbh Neue Harnstoffderivate
ES2162731B1 (es) * 1999-06-04 2003-02-16 Faes Fabrica Espanola De Produ Nuevas arilpiperacilnilalquil-3(2h)-piridacinonas.

Also Published As

Publication number Publication date
DE50100358D1 (de) 2003-08-14
HUP0102931A2 (hu) 2002-11-28
EP1176144B1 (de) 2003-07-09
CN1167698C (zh) 2004-09-22
NO20013709L (no) 2002-01-29
CZ20011813A3 (cs) 2002-03-13
US6407106B1 (en) 2002-06-18
PL210436B1 (pl) 2012-01-31
KR20020010482A (ko) 2002-02-04
EP1176144A1 (de) 2002-01-30
HK1042699A1 (en) 2002-08-23
PT1176144E (pt) 2003-11-28
NO323233B1 (no) 2007-02-05
IL144299A (en) 2004-08-31
DE10036818A1 (de) 2002-02-07
PL348946A1 (en) 2002-02-11
NZ513041A (en) 2002-12-20
ES2201007T3 (es) 2004-03-16
CN1335316A (zh) 2002-02-13
AU5767501A (en) 2002-01-31
IL144299A0 (en) 2002-05-23
NO20013709D0 (no) 2001-07-27
CZ301695B6 (cs) 2010-05-26
ATE244716T1 (de) 2003-07-15
UA73728C2 (en) 2005-09-15
RU2288918C2 (ru) 2006-12-10
AU779318B2 (en) 2005-01-13
ZA200105737B (en) 2002-01-22
HUP0102931A3 (en) 2003-07-28
HU226687B1 (en) 2009-06-29
KR100924405B1 (ko) 2009-10-29
US20020065276A1 (en) 2002-05-30
AR028743A1 (es) 2003-05-21
IN191021B (pt) 2003-09-13
TWI304403B (en) 2008-12-21
CA2354213C (en) 2010-04-27
HU0102931D0 (en) 2001-09-28
JP2002053577A (ja) 2002-02-19
CA2354213A1 (en) 2002-01-28
DZ3119A1 (fr) 2004-09-19
SK284802B6 (sk) 2005-11-03
SK7572001A3 (en) 2002-02-05
DK1176144T3 (da) 2003-10-27

Similar Documents

Publication Publication Date Title
BR0315296A (pt) Derivados do ciclohexanol espirocìclicos
AR021844A1 (es) Derivados de propanolamina aril-sustituidos, procedimientos para su preparacion, medicamentos que contienen estos compuestos y su utilizacion
BR9909565A (pt) Derivados bicìclicos do ácido hidroxâmico
BRPI0215312B8 (pt) composto, uso de um composto, composição farmacêutica, e processo para a preparação de um composto
BR9910583A (pt) Aminotetralinas n-substituìdas como ligantes para o receptor de neuropeptìdeo y y5 úteis no tratamento de obesidade e outros distúrbios
BR0307351A (pt) Composto, composição farmacêutica, método para tratar uma condição ou estado de doença mediados pela atividade de p38 quinase ou mediados por citocinas produzidas pela atividade de p38 quinase, uso de um composto, e, processo para preparar um composto
SE0101675D0 (sv) Novel composition
BR0209580A (pt) Derivados de ciclohexan-1, 4 diamina substituìdos
BR0312729A (pt) Novos derivados de indol-3-enxofre
BRPI0409109A (pt) novos compostos
PA8595901A1 (es) "n-arilheterociclos sustituidos, procedimientos para su preparacion, y su empleo como medicamentos
BRPI0312464B8 (pt) compostos inibidores de tirosina quinases, composições farmacêuticas compreendendo os mesmos, processos para fabricação e usos dos mesmos
BR9913745A (pt) Cetonas de piridina úteis como herbicidas
BR0310077A (pt) Novos compostos e sua utilização
BR0210028A (pt) Agentes antibacterianos
SE0302760D0 (sv) New compounds
BRPI0113162B8 (pt) compostos ariloxialquilaminas nao-imidazólicos e composição farmacêutica compreendendo os referidos compostos
CY1110258T1 (el) Υποκατεστημενα παραγωγα c-κυκλοεξυλομεθυλαμινης
BR0103048A (pt) Derivados de n-triazolilmetil-piperazina como antagonistas de receptores de neuroquinina
UY27548A1 (es) Sales de ácido succínico de 5,7,14-triazatetraciclo (10.3.1.02.11.04,9) exadeca-2 (11),3,5,7,9-pentaeno y composiciones farmacéuticas
BR0013311A (pt) Derivados substituìdos de 1,5-dihidropirrol-2-ona eficazes como antagonistas de receptores nmda para o tratamento de estados de dor
PA8575601A1 (es) Procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso
AR021843A1 (es) Derivados de propanolamina sustituidos con heterociclos, procedimiento para su preparacion, y su utilizacion.
BRPI0417161A (pt) compostos, composições farmacêuticas, e, uso de um composto
BR9916807A (pt) Antagonistas de 5ht1 para terapia antidepressiva

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2256 DE 01/04/2014.